We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A phase 3, randomized, double-blind, active-controlled clinical trial to compare BAT1806/BIIB800, a tocilizumab biosimilar, with tocilizumab reference product in participants with moderate-to-severe rheumatoid arthritis with inadequate response to methotrexate: treatment period 2 analysis (week 24 to week 48)
- Authors
Leng, Xiaomei; Leszczyński, Piotr; Jeka, Slawomir; Liu, Shengyun; Liu, Huaxiang; Miakisz, Malgorzata; Gu, Jieruo; Kilasonia, Lali; Stanislavchuk, Mykola; Yang, Xiaolei; Zhou, Yinbo; Dong, Qingfeng; Mitroiu, Marian; Addison, Janet; Rezk, Mourad F.; Zeng, Xiaofeng
- Publication
Arthritis Research & Therapy, 2024, Vol 26, Issue 1, p1
- ISSN
1478-6354
- Publication type
Article
- DOI
10.1186/s13075-024-03375-w